Most international ETFs hand you every stock in the world outside the U.S., including the dividend cutters, the yield traps, and the companies that have never grown a payout in their lives. Vanguard International Dividend Appreciation ETF (NYSEARCA:VIGI) takes a different approach: it only owns companies that have raised their dividend for at least seven consecutive years, then screens out the highest-yielding names to avoid those most likely to cut.
That dual filter is the whole thesis. Growth consistency signals financial discipline. Excluding the top-yielding quartile removes companies whose elevated payouts may reflect distress rather than strength. The result is roughly 400 international companies that have demonstrated growing cash flows across multiple economic cycles.
What VIGI Is Actually Built to Do
VIGI tracks the S&P Global Ex-U.S. Dividend Growers Index, a rules-based benchmark screening for dividend growth consistency rather than current yield. The fund launched in February 2016 and has grown to $9.6 billion in assets, reflecting sustained demand for quality-tilted international exposure.
The portfolio skews heavily toward developed markets. Top holdings include Swiss pharmaceutical giants Novartis at 5.19% and Roche at 4.81%, alongside Royal Bank of Canada at 4.49% and Mitsubishi UFJ Financial Group at 4.29%. Japan, Canada, Switzerland, and Western Europe dominate the geographic mix, with meaningful exposure to India through Reliance Industries. The top 10 holdings represent roughly 35% of the fund, keeping the strategy diversified but not diffuse.
The cost structure is hard to fault. At 0.07% annually, VIGI is among the cheapest international equity funds available. Portfolio turnover runs at just 14% per year, consistent with disciplined index tracking.
Income is modest by design. The current yield sits near 2%, and quarterly distributions vary meaningfully. The most recent payment was $0.565 per share, following a range across 2025 from $0.3627 to $0.5418. This is a total-return vehicle with a dividend-growth quality screen, not an income replacement strategy.
The Performance Gap Is Real and Worth Understanding
VIGI has delivered positive long-term returns. Over the past decade, the fund gained roughly 102% on a price-return basis. The Vanguard Total International Stock ETF (NYSEARCA:VXUS) returned nearly 126% over the same period.
The gap widens at shorter intervals. Over five years, VIGI gained about 20% while VXUS returned roughly 39%. Over the trailing one-year period, VIGI gained 4% against VXUS’s nearly 22%. Year-to-date in 2026, VIGI is down about 6%, while VXUS is down less than 1%.
The consistent lag reflects the quality screen working as designed in an environment that rewarded growth stocks and cyclical exposure. The filter that protects on the downside also costs on the upside.
Three Tradeoffs Investors Should Price In
- Capped upside relative to broad international: The dividend-growth screen systematically excludes parts of the international market. When cyclicals, emerging-market growth names, or high-yielding value stocks lead, VIGI will underperform a broad benchmark like VXUS. This is structural, not a temporary lag.
- Currency risk without full insulation: VIGI holds positions across the Japanese yen, Swiss franc, Canadian dollar, euro, British pound, and Indian rupee. The fund uses currency forwards for management, but this does not eliminate the exposure. A strengthening U.S. dollar will compress returns regardless of how the underlying companies perform.
- Income variability despite the dividend-growth mandate: The screening criterion is dividend growth at the company level, but VIGI’s own distributions fluctuate based on timing and magnitude of international payouts. The December 2024 distribution was $0.2619, while the June 2025 payment was $0.5418. Investors building income plans around VIGI’s quarterly check will find the variability difficult to budget around.
VIGI is structured as a quality-tilted complement within international allocations. Investors who pair it with broader international exposure get quality screening alongside wider market capture. Those who expect it to keep pace with the broader market during risk-on environments will find the quality filter works against them in those periods.
Top Gaining Stocks
Top Losing Stocks